Compare VKTX & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VKTX | QLYS |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.3B |
| IPO Year | 2014 | 2012 |
| Metric | VKTX | QLYS |
|---|---|---|
| Price | $31.70 | $86.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 13 |
| Target Price | $95.86 | ★ $133.08 |
| AVG Volume (30 Days) | ★ 2.2M | 800.9K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.99 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $321,607,000.00 |
| Revenue This Year | N/A | $9.97 |
| Revenue Next Year | N/A | $7.15 |
| P/E Ratio | ★ N/A | $63.35 |
| Revenue Growth | N/A | ★ 15.32 |
| 52 Week Low | $22.96 | $74.51 |
| 52 Week High | $43.15 | $155.47 |
| Indicator | VKTX | QLYS |
|---|---|---|
| Relative Strength Index (RSI) | 45.93 | 45.09 |
| Support Level | $30.30 | $83.60 |
| Resistance Level | $35.94 | $92.02 |
| Average True Range (ATR) | 1.55 | 4.52 |
| MACD | -0.06 | 0.39 |
| Stochastic Oscillator | 57.16 | 31.32 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.